跳至主要内容
临床试验/CTRI/2019/11/021907
CTRI/2019/11/021907尚未招募4 期

A Randomized,Open label,Parallel group study to evaluate efficacy and safety of topical Eberconazole versus topical Terbinafine in Tinea versicolor

Dr Nidarsan Viswanathan0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)age of patient more than 18 years
  • 2)patient is willing and able to provide written informed consent
  • 3)patient having a clinical diagnosis of Tinea versicolor with lesions occupying less than 10% body surface area on face,neck,upper chest and upper back.
  • 4)patients having tinea versicolor confirmed by microscopic KOH test.

排除标准

  • 1)patient age less than 18 years
  • 2)Pregnant and lactating females patients
  • 3)patients with all other types of tinea infections
  • 4)patients having history of intolerance or hypersensitivity to study drugs
  • 5)patients who had recieved systemic or topical antifungal treatment within one month.
  • 6)patients with serious concomitant illness which could prevent completion of study
  • 7)Patients who has extensive involvement with tinea versicolor and patients with contact dermatitis,atopic dermatitis,psoriasis or other skin diseases.
  • 8)patient is unwilling or unable to sign the informed consent
  • 9)patients who are taking immunosuppressive drugs.

研究者

发起方
Dr Nidarsan Viswanathan

相似试验